Everleap Fertility Rebranded Amid New Fertility Data
A national fertility network has launched under a new name while releasing findings on the prevalence of infertility among U.S. women.
Updated on Oct. 13, 2026 in Pregnancy
Live Poll
Is access to fertility treatments becoming better for the average person in the U.S.?
IVI RMA North America has officially rebranded as Everleap Fertility, a subsidiary of the Spain-based IVI Institute. The organization, which operates a network of over 65 U.S. clinics, concurrently released results from its inaugural fertility survey.
Why it matters
The company aims to consolidate its regional practices to better reflect advancements in fertility science for the millions of women navigating reproductive health challenges. This shift highlights a growing industry focus on integrating broader care networks to support the significant portion of the population dealing with infertility.
Data from the IVI Institute Fertility Barometer indicates that 21% of U.S. women have experienced infertility, while 63% of those who received IVF achieved a successful pregnancy. This survey of women who are mothers or want children remains a preliminary look at national trends.
The players
Everleap Fertility
A U.S.-based fertility provider operating over 65 clinics and 26 IVF laboratories formerly known as IVI RMA North America.
IVI Institute
The Spain-based parent organization that oversees global fertility research and clinic operations.
Conceivable Life Sciences
A biotechnology developer focused on automating embryology laboratory processes.
The details
Everleap Fertility operates more than 65 clinics and 26 IVF laboratories across the United States using a network of nine distinct practices. The organization supports its clinical care through a proprietary electronic medical records platform equipped with an AI-powered assistant to manage patient records and treatment cycles. To drive future clinical outcomes, the network is planning to integrate fully automated embryology laboratory technology.
Timeline
Everleap Fertility announced its corporate rebrand and survey findings on October 13, 2026.
The organization plans to launch its first fully automated embryology lab in 2027.
Health Landscape
The introduction of the IVI Institute Fertility Barometer marks an effort to standardize data collection across the fragmented U.S. fertility market. This move reflects a wider industry shift toward consolidating regional practices into unified national networks to scale advanced reproductive technologies.
For those experiencing challenges starting a family, these findings underscore that consulting a specialist is a common and supported step, with over 75% of women in similar situations having already sought professional care. If you are planning for pregnancy, discussing your fertility history and timeline with a physician can help you understand your specific options.
The takeaway
Large-scale fertility networks are increasingly using integrated technology to manage reproductive care for a significant segment of the population. If you are struggling with infertility, it is worth initiating a conversation with a reproductive endocrinologist to review your personal health factors.
What happens next
Everleap Fertility is scheduled to introduce the first fully automated embryology laboratory system to its U.S. clinics in 2027.
Further reading
Learn more about navigating reproductive health and clinical care options in our Pregnancy section.
Live Poll
Is access to fertility treatments becoming better for the average person in the U.S.?
